DIA's Annual Canadian Meeting: New Reality / New Frontiers

Making clinical trial information publicly accessible in registries has been identified as a key means of enhancing transparency. Various organizations, domestic and international, are currently engaged in initiatives to encourage or require registration and disclosure of clinical trial information. Regulators, industry, industry associations, medical journals, public funding agencies, patient groups and the World Health Organization (WHO) have all initiated efforts to promote transparency of clinical trials. Currently, there is no formal consensus on international norms and standards for reporting the findings of clinical trials. Clinical trial medical informatics aims to achieve the best possible support of patient care and outcome by acquiring, generating and sharing ongoing in trial information. Attend this session to learn more about the developing policy and initiatives as well as current practices and case studies in regard to enhancing health professional and public access to important therapeutic product information.